Trial Profile
A Phase IV, Multicenter, Randomized, Open Label Study To Evaluate The Efficacy And Safety Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Simvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 30 Oct 2008 Actual patient number (383) added as reported by ClinicalTrials.gov.
- 07 Aug 2007 Status changed
- 29 Oct 2005 New trial record.